drugset / Trial / NCT02928328

Assessment of Peripheral GABA Receptors for Local Pain Relief

NCT02928328

Unknown 90 enrolled Aalborg University
RandomizedParallel-groupDouble-blindBasic science

Summary

The effect of peripheral GABAA receptor activation on pain and sensitivity in healthy human subjects has never been investigated. However, as earlier studies suggest that activation of peripheral GABAA receptors is anti-nociceptive in rats, it is important to determine if these findings can be translated into human subjects to determine if peripheral GABAA receptors are a viable target for future analgesic drug development.

Timeline

Start
2016-10
Primary completion
2018-12
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Gamma-Aminobutyric Acid Small molecule 50 mmol Oral
Subject Gamma-Aminobutyric Acid Small molecule 500 mmol Oral
Subject Lidocaine Other / unclassified 1 % Oral
Subject Lorazepam Small molecule Intramuscular

Indications

No indication recorded.